An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT01384162 · TERMINATED
Trial details
- NCT number
- NCT01384162
- Sponsor
- Newron Sweden AB
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.